Goudelocke C1, Lavin V2, Perrouin-Verbe M3, Elterman D4, Peyronnet B5, Smits M6, Shah S7, Xavier K8, Krlin R9, Bukkapatnam R10, Papi B11, Gillespie E11, Sahai A12, Malde S12
1. Department of Urology, Ochsner Medical Center, New Orleans LA, USA, 2. The Newcastle upon Tyne Hospitals NHS Foundation Trust – Freeman Hospital, UK, 3. Department of Urology, Centre Hospitalier Universitaire de Nantes, Nantes, France, 4. Division of Urology, University of Toronto, Toronto, Canada, 5. Department of Urology, Centre Hospitalier Universitaire de Rennes, Rennes, France, 6. Maastricht Universitair Medisch Centrum, Maastricht, Netherlands, 7. East Coast Institute for Research LLC, Jacksonville FL, USA, 8. Urology Partners of North Texas, Arlington TX, USA, 9. Department of Urology, Louisiana State University Health Sciences Center, New Orleans LA, USA, 10. Florida Urology Partners, Tampa, FL, USA, 11. Medtronic, Minneapolis MN, USA, 12. Guys & St Thomas NHS FDN Trust-St Thomas, London, UK
Clinical Trial, Neuromodulation, Prospective Study, Voiding Dysfunction , Voiding Diary